Yatin Suneja
Stock Analyst at Guggenheim
(4.71)
# 152
Out of 5,152 analysts
158
Total ratings
59.59%
Success rate
28.6%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNTH Dianthus Therapeutics | Maintains: Buy | $100 → $200 | $62.03 | +222.42% | 3 | Mar 4, 2026 | |
| SION Sionna Therapeutics | Maintains: Buy | $45 → $50 | $34.57 | +44.63% | 1 | Mar 3, 2026 | |
| PHAT Phathom Pharmaceuticals | Maintains: Buy | $20 → $25 | $11.06 | +126.04% | 5 | Feb 27, 2026 | |
| ARGX argenx SE | Maintains: Buy | $1,160 → $1,120 | $749.56 | +49.42% | 14 | Feb 27, 2026 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $205 → $220 | $164.08 | +34.08% | 10 | Feb 24, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $760 → $800 | $325.11 | +146.07% | 5 | Feb 10, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $865 → $975 | $787.50 | +23.81% | 9 | Feb 9, 2026 | |
| BIIB Biogen | Maintains: Buy | $185 → $246 | $189.94 | +29.51% | 4 | Feb 9, 2026 | |
| ROIV Roivant Sciences | Maintains: Buy | $28 → $30 | $29.52 | +1.63% | 4 | Feb 9, 2026 | |
| IMVT Immunovant | Maintains: Buy | $41 → $44 | $27.08 | +62.48% | 9 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $18.36 | +172.33% | 1 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $32 | $28.87 | +10.84% | 3 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $3.93 | +281.68% | 1 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $51 | $22.79 | +123.78% | 2 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $22 | $0.92 | +2,303.32% | 6 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $100 | $60.55 | +65.15% | 14 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $14 | $3.05 | +359.02% | 3 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $60 | $34.99 | +71.48% | 1 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $150 | $116.77 | +28.46% | 3 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $112 → $128 | $7.57 | +1,590.89% | 3 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $20 | $18.14 | +10.25% | 4 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $31.76 | +136.15% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $15 | $3.43 | +337.32% | 6 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $175 | $133.44 | +31.15% | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $5.45 | +377.06% | 6 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $29 | $15.99 | +81.36% | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $6.99 | +114.59% | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $25.82 | +74.28% | 3 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $45 | $28.71 | +56.77% | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 | $23.39 | -14.49% | 6 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.73 | - | 2 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $65 | $41.00 | +58.54% | 1 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $90 | $29.54 | +204.67% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.65 | - | 3 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $43.05 | +13.82% | 2 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $55 | $18.00 | +205.56% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.77 | - | 3 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $18.05 | +32.96% | 1 | May 31, 2022 |
Dianthus Therapeutics
Mar 4, 2026
Maintains: Buy
Price Target: $100 → $200
Current: $62.03
Upside: +222.42%
Sionna Therapeutics
Mar 3, 2026
Maintains: Buy
Price Target: $45 → $50
Current: $34.57
Upside: +44.63%
Phathom Pharmaceuticals
Feb 27, 2026
Maintains: Buy
Price Target: $20 → $25
Current: $11.06
Upside: +126.04%
argenx SE
Feb 27, 2026
Maintains: Buy
Price Target: $1,160 → $1,120
Current: $749.56
Upside: +49.42%
Axsome Therapeutics
Feb 24, 2026
Maintains: Buy
Price Target: $205 → $220
Current: $164.08
Upside: +34.08%
Praxis Precision Medicines
Feb 10, 2026
Maintains: Buy
Price Target: $760 → $800
Current: $325.11
Upside: +146.07%
Regeneron Pharmaceuticals
Feb 9, 2026
Maintains: Buy
Price Target: $865 → $975
Current: $787.50
Upside: +23.81%
Biogen
Feb 9, 2026
Maintains: Buy
Price Target: $185 → $246
Current: $189.94
Upside: +29.51%
Roivant Sciences
Feb 9, 2026
Maintains: Buy
Price Target: $28 → $30
Current: $29.52
Upside: +1.63%
Immunovant
Feb 9, 2026
Maintains: Buy
Price Target: $41 → $44
Current: $27.08
Upside: +62.48%
Feb 2, 2026
Initiates: Buy
Price Target: $50
Current: $18.36
Upside: +172.33%
Jan 7, 2026
Maintains: Buy
Price Target: $18 → $32
Current: $28.87
Upside: +10.84%
Dec 19, 2025
Initiates: Buy
Price Target: $15
Current: $3.93
Upside: +281.68%
Dec 17, 2025
Maintains: Buy
Price Target: $35 → $51
Current: $22.79
Upside: +123.78%
Nov 10, 2025
Maintains: Buy
Price Target: $10 → $22
Current: $0.92
Upside: +2,303.32%
Nov 5, 2025
Maintains: Buy
Price Target: $90 → $100
Current: $60.55
Upside: +65.15%
Oct 27, 2025
Upgrades: Buy
Price Target: $14
Current: $3.05
Upside: +359.02%
Oct 27, 2025
Initiates: Buy
Price Target: $60
Current: $34.99
Upside: +71.48%
Oct 10, 2025
Maintains: Buy
Price Target: $101 → $150
Current: $116.77
Upside: +28.46%
Oct 8, 2025
Maintains: Buy
Price Target: $112 → $128
Current: $7.57
Upside: +1,590.89%
Sep 30, 2025
Maintains: Buy
Price Target: $80 → $20
Current: $18.14
Upside: +10.25%
Aug 18, 2025
Initiates: Buy
Price Target: $75
Current: $31.76
Upside: +136.15%
Aug 8, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $3.43
Upside: +337.32%
Aug 1, 2025
Maintains: Buy
Price Target: $165 → $175
Current: $133.44
Upside: +31.15%
Jun 25, 2025
Reiterates: Buy
Price Target: $26
Current: $5.45
Upside: +377.06%
May 9, 2025
Maintains: Buy
Price Target: $32 → $29
Current: $15.99
Upside: +81.36%
Mar 26, 2025
Reiterates: Buy
Price Target: $15
Current: $6.99
Upside: +114.59%
Mar 12, 2025
Reiterates: Buy
Price Target: $45
Current: $25.82
Upside: +74.28%
Jan 3, 2025
Upgrades: Buy
Price Target: $45
Current: $28.71
Upside: +56.77%
Jan 3, 2025
Downgrades: Neutral
Price Target: $20
Current: $23.39
Upside: -14.49%
Dec 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.73
Upside: -
Oct 25, 2024
Maintains: Buy
Price Target: $50 → $65
Current: $41.00
Upside: +58.54%
Feb 27, 2024
Maintains: Buy
Price Target: $72 → $90
Current: $29.54
Upside: +204.67%
Jul 17, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.65
Upside: -
Jun 15, 2023
Reiterates: Buy
Price Target: $49
Current: $43.05
Upside: +13.82%
May 18, 2023
Maintains: Buy
Price Target: $52 → $55
Current: $18.00
Upside: +205.56%
Oct 14, 2022
Downgrades: Neutral
Price Target: n/a
Current: $4.77
Upside: -
May 31, 2022
Initiates: Buy
Price Target: $24
Current: $18.05
Upside: +32.96%